Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001689375-23-000014

Chief Scientific Officer gave up 1,058 shares (to pay taxes)

  • Chief Scientific Officer acquired 28,400 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Sethuraman Natarajan · Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-03-01 Grant or award : show line 1 in the form +28,400 190,544 D
2023-03-02 Shares withheld for taxes : show line 2 in the form −1,058 $11.60 $12,269 189,486 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-03-01 Grant or award : show line 3 in the form Stock Option (Right to Buy) +43,000 43,000 D
Loading xslF345X03/wf-form4_167787931361377.xml…